Platelet microRNAs as Potential Novel Biomarkers for Antiplatelet Therapy with P2Y 12 Inhibitors and Their Association with Platelet Function.
Karolina GumiężnaAdrian BednarekGrażyna SygitowiczAgata Maciejak-JastrzębskaPiotr BaruśJaromir HuniaDominika Klimczak-TomaniakJanusz KochmanMarcin GrabowskiMariusz TomaniakPublished in: Journal of clinical medicine (2023)
The identified platelet miRs hold potential as biomarkers for antiplatelet therapy. (ClinicalTrials.gov number, NCT06177587).